|
Q3 FY2025
As of Nov 30, 2024
|
Q2 FY2025
As of Aug 31, 2024
|
Q1 FY2025
As of May 31, 2024
|
Q4 FY2024
As of Feb 29, 2024
|
Q3 FY2024
As of Nov 30, 2023
|
Q2 FY2024
As of Aug 31, 2023
|
Q1 FY2024
As of May 31, 2023
|
Q4 FY2023
As of Feb 28, 2023
|
Q3 FY2023
As of Nov 30, 2022
|
Q2 FY2023
As of Aug 31, 2022
|
Q1 FY2023
As of May 31, 2022
|
Q4 FY2022
As of Feb 28, 2022
|
Q3 FY2022
As of Nov 30, 2021
|
Q2 FY2022
As of Aug 31, 2021
|
Q1 FY2022
As of May 31, 2021
|
Q4 FY2021
As of Feb 28, 2021
|
Q3 FY2021
As of Nov 30, 2020
|
Q2 FY2021
As of Aug 31, 2020
|
Q1 FY2021
As of May 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Current assets: | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Marketable securities | |||||||||||||||||||
| Accounts receivable, net | |||||||||||||||||||
| Unbilled revenue | |||||||||||||||||||
| Current portion of deferred contract acquisition costs | |||||||||||||||||||
| Prepaid and other current assets | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Property and equipment, net | |||||||||||||||||||
| Operating lease right-of-use assets | |||||||||||||||||||
| Goodwill | |||||||||||||||||||
| Intangible assets, net | |||||||||||||||||||
| Deferred contract acquisition costs | |||||||||||||||||||
| Other assets | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| Liabilities and stockholders’ equity | |||||||||||||||||||
| Current liabilities: | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||||||||
| Accrued compensation | |||||||||||||||||||
| Due to customers | |||||||||||||||||||
| Current portion of deferred revenue | |||||||||||||||||||
| Current portion of operating lease liabilities | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Loans payable, net of unamortized issuance costs | |||||||||||||||||||
| Operating lease liabilities | |||||||||||||||||||
| Deferred rent and other noncurrent liabilities | |||||||||||||||||||
| Other noncurrent liabilities | |||||||||||||||||||
| Deferred revenue | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Stockholders’ equity | |||||||||||||||||||
| Common stock par value $0.0001; 500,000,000 shares authorized; 81,186,542 and 78,070,781 shares issued and outstanding at November 30, 2024 and February 29, 2024, respectively | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Accumulated other comprehensive income (loss) | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Total stockholders’ equity | |||||||||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||||||||
Loading...
